Tag Archives: AUTL

Jefferies Sticks to Its Buy Rating for Autolus Therapeutics (AUTL)

Jefferies analyst Biren Amin maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report) on June 12 and set a price target of $27.00. The company’s shares closed last Wednesday at $13.16. According to TipRanks.com, Amin is a 5-star

Autolus Therapeutics (AUTL) Gets a Buy Rating from William Blair

William Blair analyst Matt Phipps reiterated a Buy rating on Autolus Therapeutics (AUTL – Research Report) on June 12. The company’s shares closed last Tuesday at $13.04. According to TipRanks.com, Phipps is a 4-star analyst with an average return of

Autolus Therapeutics (AUTL) Received its Third Buy in a Row

After William Blair and Mizuho Securities gave Autolus Therapeutics (NASDAQ: AUTL) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Debjit Chattopadhyay reiterated a Buy rating on Autolus Therapeutics today and set a

Autolus Therapeutics (AUTL) Receives a Buy from William Blair

In a report issued on May 29, Matt Phipps from William Blair maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report). The company’s shares closed last Monday at $11.98. According to TipRanks.com, Phipps is a 4-star analyst with

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (NASDAQ: AUTL) and Madrigal Pharmaceuticals (NASDAQ: MDGL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Autolus Therapeutics (AUTL – Research Report) and Madrigal Pharmaceuticals (MDGL – Research Report) with bullish sentiments. Autolus Therapeutics (AUTL) H.C. Wainwright analyst

Autolus Therapeutics (AUTL) Gets a Buy Rating from Needham

Needham analyst Chad Messer maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report) today and set a price target of $26.00. The company’s shares closed last Thursday at $10.95. According to TipRanks.com, Messer is a 5-star analyst with